• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于干性的高级别浆液性卵巢癌预后生物标志物的鉴定

Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness.

作者信息

Wang Zhihang, Yang Lili, Huang Zhenyu, Li Xuan, Xiao Juan, Qu Yinwei, Huang Lan, Wang Yan

机构信息

Key Laboratory of Symbolic Computation and Knowledge Engineering, Ministry of Education, College of Computer Science and Technology, Jilin University, Changchun, China.

Department of Obstetrics, The First Hospital of Jilin University, Changchun, China.

出版信息

Front Genet. 2022 Mar 14;13:861954. doi: 10.3389/fgene.2022.861954. eCollection 2022.

DOI:10.3389/fgene.2022.861954
PMID:35360863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8964092/
Abstract

In this paper, high-grade serous ovarian cancer (HGSOC) is studied, which is the most common histological subtype of ovarian cancer. We use a new analytical procedure to combine the bulk RNA-Seq sample for ovarian cancer, mRNA expression-based stemness index (mRNAsi), and single-cell data for ovarian cancer. Through integrating bulk RNA-Seq sample of cancer samples from TCGA, UCSC Xena and single-cell RNA-Seq (scRNA-Seq) data of HGSOC from GEO, and performing a series of computational analyses on them, we identify stemness markers and survival-related markers, explore stem cell populations in ovarian cancer, and provide potential treatment recommendation. As a result, 171 key genes for capturing stem cell characteristics are screened and one vital cancer stem cell subpopulation is identified. Through further analysis of these key genes and cancer stem cell subpopulation, more critical genes can be obtained as LCP2, FCGR3A, COL1A1, COL1A2, MT-CYB, CCT5, and PAPPA, are closely associated with ovarian cancer. So these genes have the potential to be used as prognostic biomarkers for ovarian cancer.

摘要

在本文中,我们研究了高级别浆液性卵巢癌(HGSOC),它是卵巢癌最常见的组织学亚型。我们使用一种新的分析程序,将卵巢癌的批量RNA测序样本、基于mRNA表达的干性指数(mRNAsi)和卵巢癌的单细胞数据相结合。通过整合来自TCGA、UCSC Xena的癌症样本批量RNA测序样本以及来自GEO的HGSOC单细胞RNA测序(scRNA-Seq)数据,并对其进行一系列计算分析,我们识别出干性标志物和生存相关标志物,探索卵巢癌中的干细胞群体,并提供潜在的治疗建议。结果,筛选出171个捕获干细胞特征的关键基因,并鉴定出一个重要的癌症干细胞亚群。通过对这些关键基因和癌症干细胞亚群的进一步分析,可以获得更多关键基因,如LCP2、FCGR3A、COL1A1、COL1A2、MT-CYB、CCT5和PAPPA,它们与卵巢癌密切相关。因此,这些基因有潜力用作卵巢癌的预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/153a7c6925be/fgene-13-861954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/b395b98475b5/fgene-13-861954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/ec2e9c8f5ad3/fgene-13-861954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/081f8fd55234/fgene-13-861954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/2970519885ed/fgene-13-861954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/ed72bdb72ed5/fgene-13-861954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/153a7c6925be/fgene-13-861954-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/b395b98475b5/fgene-13-861954-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/ec2e9c8f5ad3/fgene-13-861954-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/081f8fd55234/fgene-13-861954-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/2970519885ed/fgene-13-861954-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/ed72bdb72ed5/fgene-13-861954-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8a3/8964092/153a7c6925be/fgene-13-861954-g006.jpg

相似文献

1
Identification of Prognosis Biomarkers for High-Grade Serous Ovarian Cancer Based on Stemness.基于干性的高级别浆液性卵巢癌预后生物标志物的鉴定
Front Genet. 2022 Mar 14;13:861954. doi: 10.3389/fgene.2022.861954. eCollection 2022.
2
Transcriptome-based stemness indices analysis reveals platinum-based chemo-theraputic response indicators in advanced-stage serous ovarian cancer.基于转录组的干性指数分析揭示了晚期浆液性卵巢癌中基于铂类的化疗反应指标。
Bioengineered. 2021 Dec;12(1):3753-3771. doi: 10.1080/21655979.2021.1939514.
3
Construction of monocyte-related prognosis model based on comprehensive analysis of bulk RNA-seq and single-cell RNA-seq in high-grade serous ovarian cancer.基于 bulk RNA-seq 和单细胞 RNA-seq 的高级别浆液性卵巢癌中单核细胞相关预后模型的构建。
Medicine (Baltimore). 2023 Dec 15;102(50):e36548. doi: 10.1097/MD.0000000000036548.
4
Identification of key genes controlling breast cancer stem cell characteristics via stemness indices analysis.通过干性指数分析鉴定控制乳腺癌干细胞特征的关键基因
J Transl Med. 2020 Feb 12;18(1):74. doi: 10.1186/s12967-020-02260-9.
5
Identification of key genes associated with cancer stem cell characteristics in Wilms' tumor based on bioinformatics analysis.基于生物信息学分析的肾母细胞瘤中与癌症干细胞特征相关的关键基因鉴定
Ann Transl Med. 2022 Nov;10(22):1204. doi: 10.21037/atm-22-4477.
6
Integrated analysis of scRNA-seq and bulk RNA-seq identifies as a candidate biomarker associated with chemoresistance in HGSOC.单细胞RNA测序(scRNA-seq)和批量RNA测序(bulk RNA-seq)的综合分析确定了[具体内容缺失]作为与高级别浆液性卵巢癌(HGSOC)化疗耐药相关的候选生物标志物。
Heliyon. 2024 Mar 25;10(7):e28490. doi: 10.1016/j.heliyon.2024.e28490. eCollection 2024 Apr 15.
7
Identification of biomarkers for acute leukemia via machine learning-based stemness index.基于机器学习的干性指数鉴定急性白血病的生物标志物。
Gene. 2021 Dec 15;804:145903. doi: 10.1016/j.gene.2021.145903. Epub 2021 Aug 16.
8
Identification of estrogen response-associated STRA6+ granulosa cells within high-grade serous ovarian carcinoma by single-cell sequencing.通过单细胞测序鉴定高级别浆液性卵巢癌中雌激素反应相关的STRA6+颗粒细胞。
Heliyon. 2024 Mar 8;10(6):e27790. doi: 10.1016/j.heliyon.2024.e27790. eCollection 2024 Mar 30.
9
Comparative analysis between highgrade serous ovarian cancer and healthy ovarian tissues using single-cell RNA sequencing.使用单细胞RNA测序对高级别浆液性卵巢癌与健康卵巢组织进行比较分析。
Front Oncol. 2023 Apr 14;13:1148628. doi: 10.3389/fonc.2023.1148628. eCollection 2023.
10
In silico identification of the prognostic biomarkers and therapeutic targets associated with cancer stem cell characteristics of glioma.基于生物信息学方法鉴定与胶质瘤肿瘤干细胞特征相关的预后生物标志物和治疗靶点。
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20201037.

引用本文的文献

1
Chaperonin containing TCP1 subunit 5 as a novel pan-cancer prognostic biomarker for tumor stemness and immunotherapy response: insights from multi-omics data, integrated machine learning, and experimental validation.含TCP1亚基5的伴侣蛋白作为肿瘤干性和免疫治疗反应的新型泛癌预后生物标志物:来自多组学数据、综合机器学习和实验验证的见解
Cancer Immunol Immunother. 2025 May 27;74(7):224. doi: 10.1007/s00262-025-04071-7.
2
Uncovering key regulatory pathways and prognostic biomarkers in the tumor microenvironment of high-grade serous ovarian cancer through single-cell RNA sequencing and experimental validation.通过单细胞RNA测序和实验验证揭示高级别浆液性卵巢癌肿瘤微环境中的关键调控通路和预后生物标志物。
Front Oncol. 2025 May 9;15:1591430. doi: 10.3389/fonc.2025.1591430. eCollection 2025.
3

本文引用的文献

1
Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes.通过上皮-间充质转化特征和同源重组修复基因对高级别浆液性卵巢癌进行分类。
Genes (Basel). 2021 Jul 20;12(7):1103. doi: 10.3390/genes12071103.
2
A novel prognostic biomarker LCP2 correlates with metastatic melanoma-infiltrating CD8 T cells.一种新型预后生物标志物 LCP2 与转移性黑色素瘤浸润的 CD8 T 细胞相关。
Sci Rep. 2021 Apr 28;11(1):9164. doi: 10.1038/s41598-021-88676-9.
3
Study on the Reparative Effect of PEGylated Growth Hormone on Ovarian Parameters and Mitochondrial Function of Oocytes From Rats With Premature Ovarian Insufficiency.
A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities.卵巢癌干细胞综述:与高复发率的关联、潜在机制及治疗机遇
Mol Cancer. 2025 May 7;24(1):135. doi: 10.1186/s12943-025-02345-3.
4
Integrative analysis of a novel signature incorporating metabolism and stemness-related genes for risk stratification and assessing clinical outcomes and therapeutic responses in lung adenocarcinoma.整合分析一种包含代谢和干性相关基因的新型特征用于肺腺癌的风险分层、评估临床结局和治疗反应
BMC Cancer. 2025 Apr 1;25(1):591. doi: 10.1186/s12885-025-13984-6.
5
Transcription factor networks and novel immune biomarkers reveal key prognostic and therapeutic insights in ovarian cancer.转录因子网络和新型免疫生物标志物揭示了卵巢癌关键的预后和治疗见解。
Discov Oncol. 2025 Mar 12;16(1):309. doi: 10.1007/s12672-025-01788-w.
6
Stabilization of SQLE mRNA by WTAP/FTO/IGF2BP3-dependent manner in HGSOC: implications for metabolism, stemness, and progression.WTAP/FTO/IGF2BP3依赖性方式在高级别浆液性卵巢癌中对SQLE mRNA的稳定作用:对代谢、干性和进展的影响
Cell Death Dis. 2024 Dec 1;15(12):872. doi: 10.1038/s41419-024-07257-6.
7
Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data.通过分析转录组数据,靶向 XIST 及其相关 ceRNA 网络,发现多囊卵巢综合征的治疗可能性。
Sci Rep. 2024 Mar 14;14(1):6180. doi: 10.1038/s41598-024-56524-1.
8
scRNA-seq revealed high stemness epithelial malignant cell clusters and prognostic models of lung adenocarcinoma.scRNA-seq 揭示了肺腺癌中具有高干性的上皮恶性细胞簇和预后模型。
Sci Rep. 2024 Feb 14;14(1):3709. doi: 10.1038/s41598-024-54135-4.
9
Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets.通过整合单细胞RNA测序和批量表达数据集鉴定卵巢癌预后的复发基因特征
Front Genet. 2022 Jun 8;13:823082. doi: 10.3389/fgene.2022.823082. eCollection 2022.
聚乙二醇化生长激素对卵巢早衰大鼠卵巢参数及卵母细胞线粒体功能的修复作用研究
Front Cell Dev Biol. 2021 Mar 15;9:649005. doi: 10.3389/fcell.2021.649005. eCollection 2021.
4
Bioinformatics Analysis Reveals an Association Between Cancer Cell Stemness, Gene Mutations, and the Immune Microenvironment in Stomach Adenocarcinoma.生物信息学分析揭示胃腺癌中癌细胞干性、基因突变与免疫微环境之间的关联。
Front Genet. 2020 Dec 11;11:595477. doi: 10.3389/fgene.2020.595477. eCollection 2020.
5
Identification of cancer stem cell-related biomarkers in intestinal-type and diffuse-type gastric cancer by stemness index and weighted correlation network analysis.通过干性指数和加权相关网络分析鉴定肠型和弥漫型胃癌中的癌症干细胞相关生物标志物。
J Transl Med. 2020 Nov 7;18(1):418. doi: 10.1186/s12967-020-02587-3.
6
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.同时阻断 PD-1 和 PD-L1 免疫检查点可增强高级别浆液性卵巢癌的疗效。
Cancer Res. 2021 Jan 1;81(1):158-173. doi: 10.1158/0008-5472.CAN-20-1674. Epub 2020 Nov 6.
7
Epithelial-Mesenchymal Transition in Cancer: A Historical Overview.癌症中的上皮-间质转化:历史概述
Transl Oncol. 2020 Jun;13(6):100773. doi: 10.1016/j.tranon.2020.100773. Epub 2020 Apr 22.
8
Validation of Novel Prognostic Biomarkers for Early-Stage Clear-Cell, Endometrioid and Mucinous Ovarian Carcinomas Using Immunohistochemistry.利用免疫组织化学验证早期透明细胞癌、子宫内膜样癌和黏液性卵巢癌的新型预后生物标志物
Front Oncol. 2020 Feb 18;10:162. doi: 10.3389/fonc.2020.00162. eCollection 2020.
9
Targeting signalling pathways and the immune microenvironment of cancer stem cells - a clinical update.靶向肿瘤干细胞的信号通路和免疫微环境——临床新进展。
Nat Rev Clin Oncol. 2020 Apr;17(4):204-232. doi: 10.1038/s41571-019-0293-2. Epub 2019 Dec 2.
10
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage.基于参考的肺单细胞测序分析揭示了一种过渡性成纤维细胞样巨噬细胞。
Nat Immunol. 2019 Feb;20(2):163-172. doi: 10.1038/s41590-018-0276-y. Epub 2019 Jan 14.